Blood test aims to tailor radiation, reduce side effects for breast cancer patients
NCT ID NCT06382818
Summary
This study aims to personalize radiation therapy for breast cancer patients based on their individual risk of the cancer returning and their likelihood of experiencing serious side effects. Researchers will use a blood test to predict a patient's sensitivity to radiation damage and group them into different treatment plans. The goal is to match each patient with the safest and most effective radiation dose and technique for their specific situation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institut Du Cancer de Montpellier
RECRUITINGMontpellier, France
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.